Key Lessons & Opportunities in applying NCA and PopPK to ADCs
Applying NCA and PopPK to ADCs helps decode complex PK, balance DAR effects, and guide…
CertaraOctober 24, 2025
Bottlenecks to Breakthroughs: Tackling Challenges in QSP Modeling
QSP modeling holds huge promise, but complexity and scalability limit adoption. We review the challenges…
CertaraOctober 22, 2025
Certara Scientists are Among the Topmost Cited Biopharma Researchers
Certara celebrates its 200 published papers and 11 scientists ranked in the top 2% of…
CertaraOctober 20, 2025
Certara IQ™: The Future of AI-Enabled Scalable QSP Modeling
Explore how Certara IQ redefines QSP modeling through automation, scalability, and AI assistance for faster,…
CertaraOctober 16, 2025
Immuno-oncology (IO) Simulator in Certara IQ™
Learn how Certara IQ’s IO Simulator models immune-tumor interactions and therapy outcomes to guide immuno-oncology…
CertaraOctober 16, 2025
ADC Modeling and Design with Certara IQ™
Discover how Certara IQ helps optimize antibody-drug conjugate properties through mechanistic modeling and early feasibility…
CertaraOctober 16, 2025
Prebuilt Pharmacology Models in Certara IQ™
Certara IQ Pharmacology Models | Prebuilt Mechanistic Models for Faster QSP Research
CertaraOctober 16, 2025
QSP Modeling for Inflammatory Bowel Disease (IBD) with Certara IQ™
Learn how Certara IQ’s IBD model enables simulation of complex immune pathways to optimize therapeutic…
CertaraOctober 16, 2025
Modeling Alzheimer’s Disease with Certara IQ™
Explore Certara IQ’s Alzheimer’s Disease model, enabling researchers to simulate neurodegenerative pathways, test therapies, and…
CertaraOctober 16, 2025
